Compounds > batzelladine f
Page last updated: 2024-12-08

batzelladine f

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

batzelladine F: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID490397
MeSH IDM0412149

Synonyms (8)

Synonym
188112-82-5
[1-methyl-6-(methyl[?]yl)hexyl] methyl(nonyl)[?]carboxylate
6-[(2as,4r,7r,8as)-7-methyl-2,2a,3,4,6,7,8,8a-octahydro-1h-5,6,8b-triazaacenaphthylen-4-yl]-1-methylhexyl (2as,3s,4r,8as)-4-methyl-7-nonyl-2,2a,3,4,6,7,8,8a-octahydro-1h-5,6,8b-triazaacenaphthylene-3-carboxylate
batzelladine f
6-((2as,4r,7r,8as)-7-methyl-2,2a,3,4,6,7,8,8a-octahydro-1h-5,6,8b-triazaacenaphthylen-4-yl)-1-methylhexyl (2as,3s,4r,8as)-4-methyl-7-nonyl-2,2a,3,4,6,7,8,8a-octahydro-1h-5,6,8b-triazaacenaphthylene-3-carboxylate
DTXSID50940301
7-(7-methyl-2,2a,3,4,5,7,8,8a-octahydro-1h-5,6,8b-triazaacenaphthylen-4-yl)heptan-2-yl 4-methyl-7-nonyl-2,2a,3,4,6,7,8,8a-octahydro-1h-5,6,8b-triazaacenaphthylene-3-carboxylate
7-[(1s,4s,6r,10r)-10-methyl-7,9,12-triazatricyclo[6.3.1.04,12]dodec-7-en-6-yl]heptan-2-yl (1s,4s,5s,6r)-6-methyl-10-nonyl-7,9,12-triazatricyclo[6.3.1.04,12]dodec-7-ene-5-carboxylate

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.41

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.41 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.36 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.41)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
guanidine
Guanidine: A strong organic base existing primarily as guanidium ions at physiological pH. It is found in the urine as a normal product of protein metabolism. It is also used in laboratory research as a protein denaturant. (From Martindale, the Extra Pharmacopoeia, 30th ed and Merck Index, 12th ed) It is also used in the treatment of myasthenia and as a fluorescent probe in HPLC.. guanidine : An aminocarboxamidine, the parent compound of the guanidines.		3.2760carboxamidine;
guanidines;
one-carbon compound
carbodiimides
Carbodiimides: Compounds with the general formula RN=C=NR, where R is a hydrocarbyl group.. methanediimine : A carbodiimide in which both nitrogens are unsubstituted.		2.0210carbodiimide
alpha-methyl-beta-hydroxybutyrate
2-methyl-3-hydroxybutyric acid: metabolite from isoleucine; RN given refers to cpd without isomeric designation. 3-hydroxy-2-methylbutanoic acid : A 3-hydroxy monocarboxylic acid that is butyric acid which is substituted by a methyl group and a hydroxy group at positions 2 and 3, respectively.		2.03103-hydroxy monocarboxylic acid
batzelladine d
batzelladine D: structure in first source		2.4220
batzelladine a
batzelladine A: strucutre in first source. batzelladine A : A carboxylic ester obtained by the formal condensation of (2aS,3S,4R,7R,8aS)-4-methyl-7-nonyl-2,2a,3,4,6,7,8,8a-octahydro-1H-5,6,8b-triazaacenaphthylene-3-carboxylic acid with the hydroxy group of 4-carbamimidamidobutyl (3R)-3-(9-hydroxynonyl)-1-imino-1,2,3,5,6,7-hexahydropyrrolo[1,2-c]pyrimidine-4-carboxylate. Isolated from a bright red Caribbean sponge, Batzella, it has potential anti-HIV activity.		2.7130alkaloid;
carboxylic ester;
guanidines;
organic heterotricyclic compound;
pyrrolopyrimidine;
triazaacenaphthylene		anti-HIV-1 agent;
metabolite
ptilomycalin a
ptilomycalin A: a polycyclic guanidine alkaloid from the marine sponge Ptilocaulis spiculifer; structure in first source		2.0210
ConditionIndicatedRelationship StrengthStudiesTrials